Tue. 6 Feb 2024, 4:16pm ET
Benzinga
Earnings, Earnings Beats, News
Edwards Lifesciences (NYSE:EW) reported quarterly earnings of $0.64 per share which met the analyst consensus estimate. The company reported quarterly sales of $1.53 billion which beat the analyst consensus estimate of $1.50 billion by 2.34 percent. This is a 13.50 percent increase over sales of $1.35 billion the same period last year.